SPONSOR
Groupe Francais De Pneumo-Cancerologie
Total Trials
1
Recruiting
1
Phases
N/A
Groupe Francais De Pneumo-Cancerologie is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Non-small Cell Lung Cancer, EGFR Exon 20 Insertion Mutation.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Groupe Francais De Pneumo-Cancerologie
How many clinical trials has Groupe Francais De Pneumo-Cancerologie sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Groupe Francais De Pneumo-Cancerologie, of which 1 are actively recruiting participants. These trials cover conditions including Non-small Cell Lung Cancer, EGFR Exon 20 Insertion Mutation. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Groupe Francais De Pneumo-Cancerologie research focus on?
Groupe Francais De Pneumo-Cancerologie clinical trials span Non-small Cell Lung Cancer, EGFR Exon 20 Insertion Mutation. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Groupe Francais De Pneumo-Cancerologie clinical trial?
To participate in a Groupe Francais De Pneumo-Cancerologie trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Groupe Francais De Pneumo-Cancerologie trials with current recruitment status updated daily.
Clinical Trials by Groupe Francais De Pneumo-Cancerologie
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology